Axogen to Participate at AAHS ASPN ASRM 2021 Virtual Annual Meetings
January 05 2021 - 7:00AM
Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and
marketing innovative surgical solutions for damage or transection
to peripheral nerves, today announced its participation at the
combined 2021 meetings of the
American Association for Hand
Surgery (AAHS), American Society for Peripheral Nerve
(ASPN), and the
American Society for
Reconstructive Microsurgery (ASRM). The meetings will be
held virtually from January 10-17, 2021, offering hand and
reconstructive microsurgeons the opportunity to learn about
emerging clinical evidence and surgical techniques from experts in
the field.
Axogen will host a virtual educational symposium, Recent
publications in peripheral nerve reconstruction and their
application to cutting edge techniques, on Sunday, January
17, 2021 at 8:30 p.m. ET. The symposium will
feature two renowned peripheral nerve repair experts who will
discuss the most pertinent nerve related articles published in 2020
and how they are putting this information into practice.
“We are pleased with the meetings’ agendas as they include
several presentations highlighting Axogen technologies, techniques,
and clinical studies,” said Karen Zaderej, chairman, CEO, and
president. “Interest in peripheral nerve repair continues to
increase and we welcome the opportunity to work with more surgeons
to further revolutionize the science of nerve repair.”
Presentations from Axogen’s research collaborations will be
featured in the following sessions.
AAHS:
- A comparative study of
naturally-derived SIS and cross-linked collagen as a nerve
conduit
- Comparative Effectiveness Evaluating
Allograft, Autograft, and Conduit Nerve Repairs: A Systematic
Review
- Recovery Outcomes of Median Nerve
Repairs with Processed Nerve Allograft Distal to the Elbow
ASPN:
- Patient-Reported Quality of Life and
the Impact of Delayed Referral to a Nerve Surgeon
- Impact of Nerve Surgery on Opioid and
Medication Use in Patients with Nerve Injuries
About AAHS The American Association for Hand
Surgery represents a diverse but cohesive mix of highly respected
professionals working in all disciplines of hand surgery and hand
therapy. Members include orthopedic surgeons, plastic surgeons,
general surgeons, microsurgeons, hand therapists, nurses, and basic
scientists from the United States, Canada, and many other
countries. For more information, please visit:
www.handsurgery.org.
About ASPN The American Society for Peripheral
Nerve was established to stimulate and encourage study and research
in the field of neural regeneration, to provide a forum for the
presentation of the latest research and relevant clinical
information and to serve as a unifying authority on all areas of
neural regeneration and restorative neuroscience. For more
information, please visit: www.peripheralnerve.org.
About ASRM The American Society for
Reconstructive Microsurgery was established to promote, encourage,
foster, and advance the art and science of microsurgery and complex
reconstruction and to establish a forum for teaching, research and
free discussion of reconstructive microsurgical methods and
principles. For more information, please visit:
www.microsurg.org.
About AxogenAxogen (AXGN) is the leading
company focused specifically on the science, development and
commercialization of technologies for peripheral nerve regeneration
and repair. Axogen employees are passionate about helping to
restore peripheral nerve function and quality of life to patients
with physical damage or transection to peripheral nerves by
providing innovative, clinically proven and economically effective
repair solutions for surgeons and health care providers. Peripheral
nerves provide the pathways for both motor and sensory signals
throughout the body. Every day, people suffer traumatic injuries or
undergo surgical procedures that impact the function of their
peripheral nerves. Physical damage to a peripheral nerve, or
the inability to properly reconnect peripheral nerves, can result
in the loss of muscle or organ function, the loss of sensory
feeling, or the initiation of pain.
Axogen's platform for peripheral nerve repair features a
comprehensive portfolio of products, including Avance® Nerve Graft,
a biologically active off-the-shelf processed human nerve allograft
for bridging severed peripheral nerves without the comorbidities
associated with a second surgical site; Axoguard® Nerve Connector,
a porcine submucosa extracellular matrix (ECM) coaptation aid for
tensionless repair of severed peripheral nerves; Axoguard® Nerve
Protector, a porcine submucosa ECM product used to wrap and protect
damaged peripheral nerves and reinforce the nerve reconstruction
while preventing soft tissue attachments; Axoguard® Nerve Cap, a
porcine submucosa ECM product used to protect a peripheral nerve
end and separate the nerve from the surrounding environment to
reduce the development of symptomatic or painful neuroma; and
Avive® Soft Tissue Membrane, a processed human umbilical cord
intended for surgical use as a resorbable soft tissue barrier. The
Axogen portfolio of products is available in the United States,
Canada, the United Kingdom, South Korea, and several other European
and international countries.
Contact:Axogen, Inc.
Peter Mariani, Chief Financial
OfficerInvestorRelations@axogeninc.com
Axogen (NASDAQ:AXGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Axogen (NASDAQ:AXGN)
Historical Stock Chart
From Apr 2023 to Apr 2024